clinical trial vanguard’s gastroenterology and immunology coverage

The Gut-Brain Axis Meets the Lab: Microbiome Therapies and AI in IBD Research

Introduction Inflammatory bowel disease affects more than ten million people worldwide, imposes a profound quality-of-life burden, and remains stubbornly difficult…